Convatec Group PLC (LON:CTEC)

Market Cap	4.65B -8.0%
Revenue (ttm)	1.81B +6.5%
Net Income	130.03M -8.1%
EPS	0.06 -7.5%
Shares Out	1.95B
PE Ratio	37.31
Forward PE	16.04
Dividend	0.05 (2.22%)
Ex-Dividend Date	Apr 16, 2026

Volume	12,527,220
Average Volume	9,687,014
Open	240.20
Previous Close	243.80
Day's Range	238.00 - 242.40
52-Week Range	209.40 - 311.20
Beta	0.76
RSI	51.32
Earnings Date	Feb 24, 2026

About Convatec Group

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory b...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 10,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: CTEC

Financial Performance

In 2025, Convatec Group's revenue was $2.44 billion, an increase of 6.54% compared to the previous year's $2.29 billion. Earnings were $175.00 million, a decrease of -8.14%.

Financial numbers in USD